Documenting the Natural History of Patients With Resected Stage II Adenocarcinoma of the Colon After Random Assignment to Adjuvant Treatment With Edrecolomab or Observation: Results From CALGB 9581
Year: 2020
Type: article
Study design: Clinical Trial
Abstract: We conducted a randomized trial comparing adjuvant treatment with edrecolomab versus observation in patients with resected, low-risk, stage II colon cancer. This study also prospectively studied patient- and tumor-specific markers of treatment outcome.
DOI: 10.17615/37q3-xs21
Authors: Perry, Michael C., Colacchio, Thomas A., Mayer, Robert J., Eckhardt, S. Gail, Niedzwiecki, Donna, Alberts, Steven, Kerr, David J., O'Rourke, Mark, Benson, Al Bowen, Fields, Anthony, Schwartz, Joel H., Porjosh, Gity N., Bertagnolli, Monica M., Kemeny, Nancy E., Rougier, Philippe, Pipas, J. Marc, Atkins, James, Goldberg, Richard M., Compton, Carolyn C., Warren, Robert S.
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4297938832